These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 36090999)

  • 1. Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity.
    Huang X; Zhou S; Tóth J; Hajdu A
    Front Immunol; 2022; 13():978865. PubMed ID: 36090999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma.
    Zhang X; Zhou Y; Hu J; Yu X; Xu H; Ba Z; Zhang H; Sun Y; Wang R; Du X; Mou R; Li X; Zhu J; Xie R
    BMC Cancer; 2023 Jun; 23(1):560. PubMed ID: 37330494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma.
    Liu Q; Li R; Wu H; Liang Z
    BMC Cancer; 2023 Mar; 23(1):226. PubMed ID: 36894917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma patients.
    Zhou C; Jin L; Yu J; Gao Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37322. PubMed ID: 38428843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cuproptosis-Related Gene
    Fang Z; Wang W; Liu Y; Hua J; Liang C; Liu J; Zhang B; Shi S; Yu X; Meng Q; Xu J
    Curr Oncol; 2023 Mar; 30(3):2997-3019. PubMed ID: 36975441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma.
    Yan X; Zheng W; Xu FS; Chang HL; Zhang Y; Zhang ZY; Zhang YH
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2024-2050. PubMed ID: 38497885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
    Li J; Yin J; Li W; Wang H; Ni B
    Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma.
    Wu G; Hu Q; Chen H; He M; Ma H; Zhou L; Xu K; Ren H; Qi J
    Front Oncol; 2023; 13():1127768. PubMed ID: 37007124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
    Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
    Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma.
    Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H
    Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
    Yan C; Niu Y; Ma L; Tian L; Ma J
    J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer.
    Du Y; Jiang W; Hou S; Chen Z; Zhou W
    Biomed Res Int; 2023; 2023():3419401. PubMed ID: 36714025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.
    Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P
    Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
    Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
    Front Immunol; 2021; 12():769425. PubMed ID: 34804059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma.
    Shen Y; Li D; Liang Q; Yang M; Pan Y; Li H
    Front Immunol; 2022; 13():1029092. PubMed ID: 36733399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer.
    Jin L; Mei W; Liu X; Sun X; Xin S; Zhou Z; Zhang J; Zhang B; Chen P; Cai M; Ye L
    Front Immunol; 2022; 13():974034. PubMed ID: 36203594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma.
    Wang Z; Yao J; Dong T; Niu X
    J Immunol Res; 2022; 2022():2756611. PubMed ID: 36281357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.